IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
Clinical trial NCT01534715 · COMPLETED
Trial details
- NCT number
- NCT01534715
- Sponsor
- ImmunoGen, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2016-07-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.